Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04278807
Other study ID # SSH_PENG_Trial
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 14, 2020
Est. completion date September 19, 2021

Study information

Verified date September 2021
Source Santo Spirito Hospital, Italy
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial aims to verify a possible greater analgesic efficacy of PENG (Pericapsular Nerve Group) block compared to iliac fascia block (FIB block) in elderly patients (age > 65 years) suffering from traumatic fracture of proximal femur in emergency room.


Description:

Prospective randomized double-blind single-center preliminary study aimed to demonstrate a possible greater analgesic efficacy of the PENG block compared to the iliac fascia block (FIB block) in elderly patients (age > 65 years) suffering from traumatic fracture of the proximal femur in emergency room. The study will cover patients aged > 65 years suffering from a proximal traumatic fracture of the femur who access the emergency room of Santo Spirito Hospital in Rome (ASL Roma 1).


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date September 19, 2021
Est. primary completion date September 19, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years to 105 Years
Eligibility Inclusion Criteria: - all patients > 65 years suffering from a proximal traumatic fracture of a femur who access the emergency room of Santo Spirito Hospital in Rome (ASL Rome 1), for whom surgical treatment of osteosynthesis is recommended within 48 hours in accordance with the guidelines of Regional Health System (Regione Lazio). Exclusion Criteria: - Failure to acquire written and valid informed consent - ASA > 3 - Obesity (BMI> 35 kg / m2) - Contraindications to performing regional anesthesia (severe coagulopathies and / or thrombocytopenia, septic state and / or infections at the block site, allergy to local anesthetics) - Patients on therapy with antiplatelet agents, anticoagulants or who regularly use opioids, NSAIDs, acetaminophen for chronic painful conditions; - History of alcohol or drug abuse; - Severe kidney or liver failure; - Cognitive alterations, dementia, psychiatric pathologies

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Regional Anesthesia - Nerve Blocks
Regional Anesthesia and ultrasound-guided nerve blocks

Locations

Country Name City State
Italy Santo Spirito Hospital Rome

Sponsors (1)

Lead Sponsor Collaborator
Santo Spirito Hospital, Italy

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of success rate of PENG block (defined as NRS score </ = 4 at 30 minutes from the blockade placement by comparing it to the analgesic effect of the FIB block, also evaluated at 30 minutes as NRS score </ = 4). Numeric Rating Scale (NRS-score) evaluation, from 0 (no pain) to 10 (worst pain). 30 minutes after the placement of nerve block
Secondary Onset time and duration of nerve blockade First request of analgesic medication after blockade from 30 minutes to 12 hours
Secondary Evaluation of rest and incident pain Numeric Rating Scale (NRS-score) evaluation, from 0 (no pain) to 10 (worst pain) 30 minutes after the placement of nerve block
Secondary Use of rescue-medication in pain treatment Analgesic drugs administered at the request of the patient in the case of blockade failure from 30 minutes to 12 hours
Secondary Check for any complications related to analgesic (PENG and FIB) blocks Recording of any complications related to PENG and FIB blocks from 30 minutes to 12 hours